INSL3
Title: INS-L3: A Novel Biomarker for Early Detection and Management of Diabetes
Description:
INS-L3, also known as insulin-like 3, is a hormone produced by the beta cells of the pancreas. It has emerged as a promising biomarker for the detection and management of diabetes, particularly type 1 and type 2 diabetes. INS-L3 levels can indicate the functional capacity of the beta cells and serve as an early warning sign of diabetes development.
Associated Diseases:
INS-L3 is primarily associated with the following diseases:
-
Type 1 Diabetes: In type 1 diabetes, the immune system mistakenly attacks and destroys the beta cells, leading to insulin deficiency. INS-L3 levels are significantly decreased in individuals with type 1 diabetes.
-
Type 2 Diabetes: In type 2 diabetes, the body becomes resistant to insulin, resulting in impaired glucose metabolism. INS-L3 levels may be reduced or impaired in individuals with type 2 diabetes, indicating beta cell dysfunction.
-
Gestational Diabetes: INS-L3 levels can also be used to assess the risk of gestational diabetes in pregnant women. Low INS-L3 levels have been linked to an increased risk of developing gestational diabetes.
Did you Know ?
According to the International Diabetes Federation, over 537 million people worldwide have diabetes, with type 2 diabetes accounting for approximately 90% of cases. INS-L3 measurement can significantly improve the early detection and management of diabetes, potentially reducing the burden of this global health epidemic.
